Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant attention recently because of its effectiveness in weight management. Originally developed for treating type 2 diabetes, semaglutide functions by mimicking the effects of the GLP-1 hormone, which regulates appetite and food intake. The drug functions by slowing gastric emptying, promoting an atmosphere of...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian